BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15141268)

  • 1. Clinical and economic outcomes of preterm labor management: inpatient vs outpatient.
    Ambrose S; Rhea DJ; Istwan NB; Collins A; Stanziano G
    J Perinatol; 2004 Aug; 24(8):515-9. PubMed ID: 15141268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing perinatal outcomes: the clinical benefit and cost-effectiveness of pharmacologic treatment of recurrent preterm labor.
    Lam F; Istwan NB; Jacques D; Coleman SK; Stanziano GJ
    Manag Care; 2003 Jul; 12(7):39-46. PubMed ID: 12891954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy and economic outcomes in patients treated for recurrent preterm labor.
    Fleming A; Bonebrake R; Istwan N; Rhea D; Coleman S; Stanziano G
    J Perinatol; 2004 Apr; 24(4):223-7. PubMed ID: 14999214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
    de la Torre L; Istwan NB; Desch C; Rhea DJ; Roca L; Stanziano GJ; González-Quintero VH
    Am J Perinatol; 2008 Oct; 25(9):555-60. PubMed ID: 18773381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interval to spontaneous delivery following discontinuation of maintenance tocolysis.
    Jones JS; Morrison J; Istwan N; Rhea D; Collins A; Stanziano G
    J Matern Fetal Neonatal Med; 2006 Jun; 19(6):331-5. PubMed ID: 16801308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy prolongation in triplet pregnancies. Oral vs. continuous subcutaneous terbutaline.
    Elliott JP; Bergauer NK; Jacques DL; Coleman SK; Stanziano GJ
    J Reprod Med; 2001 Nov; 46(11):975-82. PubMed ID: 11762154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of oral nifedipine versus terbutaline injection in preterm labor.
    Laohapojanart N; Soorapan S; Wacharaprechanont T; Ratanajamit C
    J Med Assoc Thai; 2007 Nov; 90(11):2461-9. PubMed ID: 18181335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An examination of the clinical benefits and cost-effectiveness of tocolytic replacement following recurrent preterm labor.
    Flick AA; de la Torre L; Roca LE; Istwan N; Rhea D; Desch C; González-Quintero VH
    Am J Perinatol; 2010 Jan; 27(1):53-9. PubMed ID: 19823965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous terbutaline administration prolongs pregnancy after recurrent preterm labor.
    Morrison JC; Chauhan SP; Carroll CS; Bofill JA; Magann EF
    Am J Obstet Gynecol; 2003 Jun; 188(6):1460-5; discussion 1465-7. PubMed ID: 12824979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost effectiveness of stopping preterm labor with beta-adrenergic treatment.
    Korenbrot CC; Aalto LH; Laros RK
    N Engl J Med; 1984 Mar; 310(11):691-6. PubMed ID: 6142417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and cost-effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for treatment of recurrent preterm labor in twin gestations.
    Lam F; Bergauer NK; Jacques D; Coleman SK; Stanziano GJ
    J Perinatol; 2001; 21(7):444-50. PubMed ID: 11894512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocolysis of preterm contractions does not improve preterm delivery rate or perinatal outcomes.
    Sciscione AC; Stamilio DM; Manley JS; Shlossman PA; Gorman RT; Colmorgen GH
    Am J Perinatol; 1998 Mar; 15(3):177-81. PubMed ID: 9572373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery.
    Wenstrom KD; Weiner CP; Merrill D; Niebyl J
    Am J Perinatol; 1997 Feb; 14(2):87-91. PubMed ID: 9259905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of terbutaline and magnesium sulfate in the management of preterm labor.
    Surichamorn P
    J Med Assoc Thai; 2001 Jan; 84(1):98-104. PubMed ID: 11281506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalization for women with arrested preterm labor: a randomized trial.
    Yost NP; Bloom SL; McIntire DD; Leveno KJ
    Obstet Gynecol; 2005 Jul; 106(1):14-8. PubMed ID: 15994611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of aggressive tocolysis for preterm labor with advanced cervical dilatation.
    Psomiadis N; Goldkrand J
    J Matern Fetal Neonatal Med; 2005 Jul; 18(1):47-52. PubMed ID: 16105791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of elective cessation of tocolysis and preterm birth in singleton gestations.
    Rebarber A; Cleary-Goldman J; Istwan N; Rhea D; Stanziano G; Saltzman D
    Am J Perinatol; 2009 May; 26(5):351-5. PubMed ID: 19067281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocolytic treatment for preterm contractions with and without cervical changes.
    Brown HL; Hiett AK; Britton KA; Turnquest MA; Golichowski AM
    Am J Perinatol; 1997 Aug; 14(7):405-9. PubMed ID: 9263560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of acute tocolysis on neonatal outcome in women hospitalized with preterm labor at 32 to 34 weeks' gestation.
    Elliott JP; Istwan NB; Rhea DJ; Desch CN; Stanziano GJ
    Am J Perinatol; 2009 Feb; 26(2):123-8. PubMed ID: 18850519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic administration to patients with preterm labor and intact membranes: is there a beneficial effect in patients with endocervical inflammation?
    Ovalle A; Romero R; Gómez R; Martínez MA; Nien JK; Ferrand P; Aspillaga C; Figueroa J
    J Matern Fetal Neonatal Med; 2006 Aug; 19(8):453-64. PubMed ID: 16966109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.